Long-term human albumin therapy failed to significantly improve long-term survival outcomes in cirrhotic patients with acute decompensation and ascites, the phase III randomized PRECIOSA trial showed.

JUNCTION CITY, Kan.--(BUSINESS WIRE)--InVitria, a leading developer of recombinant, chemically defined components for biomanufacturing, has announced the launch of Optibumin® 25, the first and only ...

Albumin is a major prognostic factor for patients with advanced liver disease, dependent on its concentration and biological activity. This study aimed to improve the method of active albumin ...

Washington, DC (Tuesday, June 24, 2008) — Healthy individuals with higher levels of albumin excretion, even levels considered normal, are at increased risk of developing hypertension (high blood ...

An A/G ratio is a blood test that compares the amount of albumin and globulin in your blood. A normal A/G ratio is between 1.1 and 2.5. A low A/G ratio may be due to kidney disease, liver disease, ...